Other
Net cash related to derivative contracts under collateral exchange arrangements
Idexx Laboratories Net cash related to derivative contracts under collateral exchange arrangements decreased by 30.9% to $1.04M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 149.8%, from $416K to $1.04M.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2021
Last reportedQ1 2026May 5, 2026
Metric ID:
other_proceeds_from_hedge_investing_activitiesHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $0 | $0 | $0 | $6.26M | $2.12M | $329K | $398K | $415K | $416K | $416K | $474K | $349K | $1.5M | $1.04M |
| QoQ Change | — | — | — | — | — | — | — | -66.1% | -84.5% | +21.0% | +4.3% | +0.2% | +0.0% | +13.9% | -26.4% | +330.9% | -30.9% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | -93.4% | -80.4% | +26.4% | +19.1% | -15.9% | +261.5% | +149.8% |
Range$0 – $6.26M
Avg YoY Growth+38.2%
Median YoY Growth+19.1%
Net cash related to derivative contracts under collateral exchange arrangements at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's net cash related to derivative contracts under collateral exchange arrangements?
- Idexx Laboratories (IDXX) reported net cash related to derivative contracts under collateral exchange arrangements of $1.04M in Q1 2026.
- How has Idexx Laboratories's net cash related to derivative contracts under collateral exchange arrangements changed year-over-year?
- Idexx Laboratories's net cash related to derivative contracts under collateral exchange arrangements increased by 149.8% year-over-year, from $416K to $1.04M.